Home › Steatotic Liver Disease › Tennessee › Chattanooga
Steatotic Liver Disease clinical trials in Chattanooga, TN
4 studies for Steatotic Liver Disease are looking for participants at sites in and around Chattanooga (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Chattanooga
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Galen Medical Group - Galen Hepatology, Chattanooga
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Chattanooga
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Chattanooga
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
Other studies in Chattanooga
- Non-Small Cell Lung Cancer11 studies
- Metastatic Cancer6 studies
- Myasthenia Gravis6 studies
- Ovarian Cancer5 studies
- Diabetes4 studies
- Melanoma4 studies
- Ischemic Stroke4 studies
- Colorectal Cancer4 studies
- Chronic Kidney Disease4 studies
- Lung Cancer4 studies
- Kidney Failure3 studies
- Atherosclerosis3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.